Goldman Sachs
VTYX

Goldman Sachs’s Ventyx Biosciences VTYX Stock Holding History

Goldman Sachs’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-420,000
Closed -$3.79M – 7023
2025
Q4 		$3.79M Buy
+420,000
New +$3.14M ﹤0.01% 4003

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's VTYX Position: Q1 2026 in Review

Goldman Sachs sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 837,602 shares — an estimated $7.56M sold.

Goldman Sachs first reported a position in VTYX in Q2 2022 and held it in 15 quarters. The position peaked at $56.1M in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Goldman Sachs reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 837,602 Ventyx Biosciences shares in Q1 2026, an estimated $7.56M.
  • Goldman Sachs first reported a position in Ventyx Biosciences in Q2 2022 and held it in 15 quarters.
  • Goldman Sachs's Ventyx Biosciences position peaked at $56.1M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.